financetom
Business
financetom
/
Business
/
BrightSpring Health Completes Acquisition of Assets Providing Hospice Services in Florida
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BrightSpring Health Completes Acquisition of Assets Providing Hospice Services in Florida
Sep 5, 2024 1:48 AM

05:29 PM EDT, 09/03/2024 (MT Newswires) -- BrightSpring Health Services ( BTSG ) said Tuesday it completed the acquisition of the assets of North Central Florida Hospice and Haven Medical Group, a Florida-based firm, effective Sunday.

The acquisition is valued at $60 million, with $15 million paid in cash on Sunday, $30 million in company equity granted on the same date, and $15 million in a seller note due on Sept. 1, 2028, the company said.

Price: 12.58, Change: +0.06, Percent Change: +0.48

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Flow Beverage Q3 Adjusted Loss Narrows as Net Revenue Rises
Flow Beverage Q3 Adjusted Loss Narrows as Net Revenue Rises
Sep 17, 2024
07:54 AM EDT, 09/17/2024 (MT Newswires) -- Flow Beverage ( FLWBF ) on Tuesday said its third-quarter adjusted loss narrowed while net revenue rose slightly. The water company said its adjusted net loss fell to $5.6 million from $12.25 million in the year-ago quarter. Consolidated net revenue rose 5% to $13.8 million. Brand net revenue contracted 15% to $8.4 million,...
Vigil Neuroscience Says FDA Lifts Partial Hold on Phase 1 Trial of Potential Alzheimer's Drug
Vigil Neuroscience Says FDA Lifts Partial Hold on Phase 1 Trial of Potential Alzheimer's Drug
Sep 17, 2024
07:49 AM EDT, 09/17/2024 (MT Newswires) -- Vigil Neuroscience ( VIGL ) said Tuesday that the US Food and Drug Administration has removed the partial hold on its phase 1 clinical trial of VG-3927, a potential therapy for Alzheimer's disease, based on a complete response it submitted to the agency. The company said it has started dosing a group of...
BridgeBio Pharma Says Infigratinib Receives US FDA Breakthrough Therapy Designation
BridgeBio Pharma Says Infigratinib Receives US FDA Breakthrough Therapy Designation
Sep 17, 2024
07:57 AM EDT, 09/17/2024 (MT Newswires) -- BridgeBio Pharma ( BBIO ) said Tuesday that the US Food and Drug Administration has granted Breakthrough Therapy Designation to oral infigratinib, which the biopharmaceutical company is developing to treat children with achondroplasia. Shares of BridgeBio Pharma ( BBIO ) were up 1.8% in recent Tuesday premarket activity. Price: 26.75, Change: +0.56, Percent...
Top Premarket Decliners
Top Premarket Decliners
Sep 17, 2024
07:48 AM EDT, 09/17/2024 (MT Newswires) -- Netcapital ( NCPL ) shares slumped 28% pre-bell Tuesday after the company reported a wider fiscal Q1 loss on lower revenue. Bone Biologics ( BBLG ) shares fell 15%, paring Monday's 136% rally. Dermata Therapeutics ( DRMA ) shares were down 9% after the company priced a $3.5 million private placement of common...
Copyright 2023-2026 - www.financetom.com All Rights Reserved